Results 51 to 60 of about 171,828 (231)
Management of Barrett’s Esophagus [PDF]
Canadian Journal of Gastroenterology and Hepatology, 2000 There have been major recent advances in the understanding of the pathogenesis and epidemiology of Barrett’s esophagus and adenocarcinoma of the esophagus. The advent of potent acid suppression with proton pump inhibitors and safe, minimally invasive antireflux procedures has made alleviating symptoms and eliminating peptic complications achievable ...
Ziad Younes +2 more
openaire +3 more sources
ANZ Journal of Surgery, EarlyView.Anti‐reflux and paraoesophageal hernia surgery rates in Australia rose markedly from 2000 to 2024, especially among females and older adults. Hiatal closure procedures increased while isolated fundoplasty declined, highlighting shifting surgical practice and notable sex‐ and age‐related differences in treatment patterns.
Christopher Goubar +3 more
wiley +1 more source
Gastro Hep Advances, 2022 Background and Aims: Esophageal adenocarcinoma (EAC) incidence has risen dramatically in the Western countries over the past decades. The underlying reasons are incompletely understood, and shifts in the esophageal microbiome have been postulated to ...
Nikole Radani +14 more
doaj +1 more source
ANZ Journal of Surgery, EarlyView.ABSTRACT Background There is compelling evidence that treating high‐grade squamous intraepithelial lesions (HSIL), the anal squamous cell cancer (ASCC) precursor, reduces the risk of developing ASCC. Using high‐resolution anoscopy (HRA), surgical excision, ablative and topical therapies are widely used to treat HSIL.
Matthew Joseph Marino +5 more
wiley +1 more source
ANZ Journal of Surgery, EarlyView.Impact of routine POOGD with routine biopsies on surgical management in 423 patients undergoing RYGB. ABSTRACT Introduction The role of routine preoperative oesophagogastroduodenoscopy (POOGD) with routine biopsies prior to Roux‐en‐Y gastric bypass (RYGB) remains controversial.
Shahab Valizadehzare, Michael Hatzifotis
wiley +1 more source
The Turkish Journal of Gastroenterology, 2017 Cite this article as: Bor S, Sarıtaş Yüksel E. How is the gastroesophageal reflux disease prevalence, incidence, and frequency of complications (stricture/ esophagitis/Barrett’s esophagus/carcinoma) in Turkey compared to other geographical ...
Serhat Bor, Elif Sarıtaş Yüksel
doaj +1 more source
Mechanisms underpinning the progression of nondysplastic Barrett's oesophagus to cancer
The FEBS Journal, EarlyView.Barrett's oesophagus confers a low but significant cancer risk. The condition is common but we do not have effective biomarkers to identify susceptible patients. We believe that there is no single factor that determines cancer risk and an understanding of the combinations of interactions (via gene expression and natural selection) between the Barrett's
Yannick H. Derwa +2 more
wiley +1 more source
A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia
, 2011 Context.—Barrett esophagus is a metaplastic, premalignant lesion associated with approximately 0.5% annual incidence of progression to esophageal adenocarcinoma.
Montgomery, EA +8 more
core +1 more source
Esófago de Barrett y su manejo Barrett's esophagus and its management
Revista Colombiana de Cirugía, 2005 Se hace un recuento histórico del esófago de Barrett desde su descripción por Norman Barrett en 1950. Se discute la evolución del concepto. Se definen el esófago de Barrett corto y largo, su prevalencia y diagnóstico.
Mario Melguizo Bermúdez
doaj
Evaluation of p53 protein expression in Barrett esophagus
Indian Journal of Pathology and Microbiology, 2018 Background: Loss of heterozygosity of p53 along with aneuploidy is deemed to be the early molecular steps in Barrett metaplasia-dysplasia-adenocarcinoma sequence.
Mahathi Krothapalli +6 more
doaj +1 more source